HCPCS Level II

HCPCS Level II 2012 code changes

Every HCPCS Level II code whose CMS add date or termination date falls in 2012, grouped by effective date. Each code's own page carries its full record.

253

Added

Deleted

For HCPCS Level II, MedCoder records each code's CMS add date and termination date from the alpha-numeric file. A deletion is listed on the first day the code is no longer valid (the day after its CMS termination date). Description revisions between quarterly files are not recorded as changes.

Added effective January 1, 2012 (228)

A5056 — Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each
A5057 — Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each
A9272 — Wound suction, disposable, includes dressing, all accessories and components, any type, each
A9584 — Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries
A9585 — Injection, gadobutrol, 0.1 ml
C1886 — Catheter, extravascular tissue ablation, any modality (insertable)
E0988 — Manual wheelchair accessory, lever-activated, wheel drive, pair
E2358 — Power wheelchair accessory, group 34 non-sealed lead acid battery, each
E2359 — Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)
E2626 — Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable
E2627 — Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type
E2628 — Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining
E2629 — Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)
E2630 — Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support
E2631 — Wheelchair accessory, addition to mobile arm support, elevating proximal arm
E2632 — Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control
E2633 — Wheelchair accessory, addition to mobile arm support, supinator
G0448 — Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing
G0451 — Development testing, with interpretation and report, per standardized instrument form
G0908 — Most recent hemoglobin (hgb) level > 12.0 g/dl
G0909 — Hemoglobin level measurement not documented, reason not given
G0910 — Most recent hemoglobin level <= 12.0 g/dl
G0913 — Improvement in visual function achieved within 90 days following cataract surgery
G0914 — Patient care survey was not completed by patient
G0915 — Improvement in visual function not achieved within 90 days following cataract surgery
G0916 — Satisfaction with care achieved within 90 days following cataract surgery
G0917 — Patient care survey was not completed by patient
G0918 — Satisfaction with care not achieved within 90 days following cataract surgery
G0919 — Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit
G0920 — Type, anatomic location, and activity all documented
G0921 — Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)
G0922 — No documentation of disease type, anatomic location, and activity, reason not given
G8694 — Current or prior left ventricular ejection fraction (lvef) < = 40% or documentation of moderate or severe lvsd
G8696 — Antithrombotic therapy prescribed at discharge
G8697 — Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))
G8698 — Antithrombotic therapy was not prescribed at discharge, reason not given
G8699 — Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge
G8700 — Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge
G8701 — Rehabilitation services were not ordered, reason not otherwise specified
G8702 — Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively
G8703 — Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively
G8704 — 12-lead electrocardiogram (ecg) performed
G8705 — Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)
G8706 — Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)
G8707 — 12-lead electrocardiogram (ecg) not performed, reason not given
G8708 — Patient not prescribed antibiotic
G8709 — Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)
G8710 — Patient prescribed antibiotic
G8711 — Prescribed antibiotic on or within 3 days after the episode date
G8712 — Antibiotic not prescribed or dispensed
G8713 — Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])
G8714 — Hemodialysis treatment performed exactly three times per week for > 90 days
G8717 — Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given
G8718 — Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])
G8720 — Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])
G8721 — Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report
G8722 — Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)
G8723 — Specimen site is other than anatomic location of primary tumor
G8724 — Pt category, pn category and histologic grade were not documented in the pathology report, reason not given
G8725 — Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)
G8726 — Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)
G8728 — Fasting lipid profile not performed, reason not given
G8730 — Pain assessment documented as positive using a standardized tool and a follow-up plan is documented
G8731 — Pain assessment using a standardized tool is documented as negative, no follow-up plan required
G8732 — No documentation of pain assessment, reason not given
G8733 — Elder maltreatment screen documented as positive and a follow-up plan is documented
G8734 — Elder maltreatment screen documented as negative, follow-up is not required
G8735 — Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given
G8736 — Most current ldl-c <100mg/dl
G8737 — Most current ldl-c >=100mg/dl
G8738 — Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function
G8739 — Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
G8740 — Left ventricular ejection fraction (lvef) not performed or assessed, reason not given
G8749 — Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)
G8751 — Smoking status and exposure to second hand smoke in the home not assessed, reason not given
G8752 — Most recent systolic blood pressure < 140 mmhg
G8753 — Most recent systolic blood pressure >= 140 mmhg
G8754 — Most recent diastolic blood pressure < 90 mmhg
G8755 — Most recent diastolic blood pressure >= 90 mmhg
G8756 — No documentation of blood pressure measurement, reason not given
G8757 — All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient
G8758 — All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient
G8759 — All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient
G8761 — All quality actions for the applicable measures in the dementia measures group have been performed for this patient
G8762 — All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient
G8763 — All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient
G8764 — All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient
G8765 — All quality actions for the applicable measures in the cataract measures group have been performed for this patient
G8767 — Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)
G8768 — Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8769 — Lipid profile not performed, reason not given
G8770 — Urine protein test result documented and reviewed
G8771 — Documentation of diagnosis of chronic kidney disease
G8772 — Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)
G8773 — Urine protein test was not performed, reason not given
G8774 — Serum creatinine test result documented and reviewed
G8775 — Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8776 — Serum creatinine test not performed, reason not given
G8777 — Diabetes screening test performed
G8778 — Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8779 — Diabetes screening test not performed, reason not given
G8780 — Counseling for diet and physical activity performed
G8781 — Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8782 — Counseling for diet and physical activity not performed, reason not given
G8783 — Normal blood pressure reading documented, follow-up not required
G8784 — Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)
G8785 — Blood pressure reading not documented, reason not given
G8797 — Specimen site other than anatomic location of esophagus
G8798 — Specimen site other than anatomic location of prostate
G8806 — Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented
G8807 — Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has a documented intrauterine pregnancy [iup])
G8808 — Trans-abdominal or trans-vaginal ultrasound not performed, reason not given
G8809 — Rh-immunoglobulin (rhogam) ordered
G8810 — Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)
G8811 — Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given
G8815 — Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)
G8816 — Statin medication prescribed at discharge
G8817 — Statin therapy not prescribed at discharge, reason not given
G8818 — Patient discharge to home no later than post-operative day #7
G8825 — Patient not discharged to home by post-operative day #7
G8826 — Patient discharged to home no later than post-operative day #2 following evar
G8833 — Patient not discharged to home by post-operative day #2 following evar
G8834 — Patient discharged to home no later than post-operative day #2 following cea
G8838 — Patient not discharged to home by post-operative day #2 following cea
G8839 — Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness
G8840 — Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)
G8841 — Sleep apnea symptoms not assessed, reason not given
G8842 — Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea
G8843 — Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a respiratory disturbance index (rdi), or a respiratory event index (rei) within 2 months after initial evaluation for suspected obstructive sleep apnea (e.g., medical, neurological, or psychiatric disease that prohibits successful completion of a sleep study, patients for whom a sleep study would present a bigger risk than benefit or would pose an undue burden, dementia, patients previously diagnosed with osa and severity assessed by another provider, patients who decline ahi/rdi/rei measurement, patients who had a financial reason for not completing testing, test was ordered but not completed, patients decline because their insurance (payer) does not cover the expense)
G8844 — Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory event index (rei) not documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea, reason not given
G8845 — Positive airway pressure therapy prescribed
G8846 — Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)
G8848 — Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)
G8849 — Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)
G8850 — Positive airway pressure therapy not prescribed, reason not given
G8851 — Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented)
G8852 — Positive airway pressure therapy was prescribed
G8853 — Positive airway pressure therapy not prescribed
G8854 — Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy)
G8855 — Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given
G8856 — Referral to a physician for an otologic evaluation performed
G8857 — Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)
G8858 — Referral to a physician for an otologic evaluation not performed, reason not given
G8859 — Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
G8860 — Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
G8861 — Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed
G8862 — Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days
G8863 — Patients not assessed for risk of bone loss, reason not given
G8864 — Pneumococcal vaccine administered or previously received
G8865 — Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
G8866 — Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
G8867 — Pneumococcal vaccine not administered or previously received, reason not given
G8868 — Patients receiving a first course of anti-tnf therapy
G8869 — Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
G8870 — Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
G8871 — Patient not receiving a first course of anti-tnf therapy
G8872 — Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
G8873 — Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)
G8874 — Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
G8875 — Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G8876 — Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)
G8877 — Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given
G8878 — Sentinel lymph node biopsy procedure performed
G8879 — Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer
G8880 — Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)
G8881 — Stage of breast cancer is greater than t1n0m0 or t2n0m0
G8882 — Sentinel lymph node biopsy procedure not performed, reason not given
G8883 — Biopsy results reviewed, communicated, tracked and documented
G8884 — Clinician documented reason that patient's biopsy results were not reviewed
G8885 — Biopsy results not reviewed, communicated, tracked or documented
G8886 — Most recent blood pressure under control
G8887 — Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8888 — Most recent blood pressure not under control, results documented and reviewed
G8889 — No documentation of blood pressure measurement, reason not given
G8890 — Most recent ldl-c under control, results documented and reviewed
G8891 — Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8892 — Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)
G8893 — Most recent ldl-c not under control, results documented and reviewed
G8894 — Ldl-c not performed, reason not given
G8895 — Oral aspirin or other antithrombotic therapy prescribed
G8896 — Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)
G8897 — Oral aspirin or other antithrombotic therapy was not prescribed, reason not given
G8898 — I intend to report the chronic obstructive pulmonary disease (copd) measures group
G8899 — I intend to report the inflammatory bowel disease (ibd) measures group
G8900 — I intend to report the sleep apnea measures group
G8902 — I intend to report the dementia measures group
G8903 — I intend to report the parkinson's disease measures group
G8904 — I intend to report the hypertension (htn) measures group
G8905 — I intend to report the cardiovascular prevention measures group
G8906 — I intend to report the cataract measures group
G9156 — Evaluation for wheelchair requiring face to face visit with physician
J0131 — Injection, acetaminophen, not otherwise specified,10 mg
J0221 — Injection, alglucosidase alfa, (lumizyme), 10 mg
J0257 — Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
J0490 — Injection, belimumab, 10 mg
J0588 — Injection, incobotulinumtoxin a, 1 unit
J0712 — Injection, ceftaroline fosamil, 10 mg
J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
J0897 — Injection, denosumab, 1 mg
J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1725 — Injection, hydroxyprogesterone caproate, 1 mg
J2265 — Injection, minocycline hydrochloride, 1 mg
J2507 — Injection, pegloticase, 1 mg
J7131 — Hypertonic saline solution, 1 ml
J7180 — Injection, factor xiii (antihemophilic factor, human), 1 i.u.
J7183 — Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
J7326 — Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
J7665 — Mannitol, administered through an inhaler, 5 mg
J9043 — Injection, cabazitaxel, 1 mg
J9179 — Injection, eribulin mesylate, 0.1 mg
J9228 — Injection, ipilimumab, 1 mg
L5312 — Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system
L6715 — Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement
L6880 — Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)
Q0162 — Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Q4122 — Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure)
Q4123 — Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure)
Q4124 — Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
Q4125 — Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure)
Q4126 — Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure)
Q4127 — Talymed, per square centimeter (add-on, list separately in addition to primary procedure)
Q4128 — Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure)
Q4129 — Unite biomatrix, per square centimeter
Q4130 — Strattice tm, per square centimeter (add-on, list separately in addition to primary procedure)
S0119 — Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
S3722 — Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
S8130 — Interferential current stimulator, 2 channel
S8131 — Interferential current stimulator, 4 channel

Added effective April 1, 2012 (19)

C9290 — Injection, bupivacaine liposome, 1 mg
C9733 — Non-ophthalmic fluorescent vascular angiography
G8907 — Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility
G8908 — Patient documented to have received a burn prior to discharge
G8909 — Patient documented not to have received a burn prior to discharge
G8910 — Patient documented to have experienced a fall within asc
G8911 — Patient documented not to have experienced a fall within ambulatory surgical center
G8912 — Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
G8913 — Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
G8914 — Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc
G8915 — Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc
G8916 — Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time
G8917 — Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time
G8918 — Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
S0353 — Treatment planning and care coordination management for cancer, initial treatment
S0354 — Treatment planning and care coordination management for cancer, established patient with a change of regimen
S0596 — Phakic intraocular lens for correction of refractive error
S3721 — Prostate cancer antigen 3 (pca3) testing
S8930 — Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient

Added effective July 1, 2012 (3)

Q2034 — Influenza virus vaccine, split virus, for intramuscular use (agriflu)
Q2049 — Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
S1090 — Mometasone furoate sinus implant, 370 micrograms

Added effective August 2, 2012 (2)

G0459 — Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
G0460 — Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment

Added effective October 1, 2012 (1)

C9293 — Injection, glucarpidase, 10 units

Source: CMS HCPCS Level II alpha-numeric file (add and termination dates).

Source data

Source organization: CMS
Source release: HCPCS Level II October 2026 alpha-numeric file
Source file: october-2026-alpha-numeric-hcpcs-file.zip
File checksum (SHA-256): c25240c63108756d4ba6c0ea785c517117d83bfed9526c51da8acf123de1feb6
Data read date: Data not available in the current MedCoder release record.
Effective date: CMS effective dates within 2012
Release type: Quarterly (January, April, July, October), with occasional mid-quarter additions
Methodology: Each code's add date and termination date are read from the alpha-numeric file. A deletion is dated the first day the code is no longer valid, the day after its termination date. Description revisions are not recorded as changes.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

All releases in the Change Ledger